Cargando…
Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 1 newly diagnosed disease
BACKGROUND: Glioblastoma (GB) is the most common malignant brain tumor with a dismal prognosis despite standard of care (SOC). Here we used a network meta-analysis on treatments from randomized control trials (RCTs) to assess the effect on overall survival (OS) and progression-free survival (PFS) be...
Autores principales: | Taslimi, Shervin, Ye, Vincent C, Zadeh, Gelareh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134529/ https://www.ncbi.nlm.nih.gov/pubmed/34042102 http://dx.doi.org/10.1093/noajnl/vdab028 |
Ejemplares similares
-
Erratum to: Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 1 newly diagnosed disease
por: Taslimi, Shervin, et al.
Publicado: (2021) -
Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 2 recurrent glioblastoma
por: Taslimi, Shervin, et al.
Publicado: (2021) -
Avelumab in newly diagnosed glioblastoma
por: Jacques, Francois H, et al.
Publicado: (2021) -
Advances in the treatment of newly diagnosed glioblastoma
por: Theeler, Brett J., et al.
Publicado: (2015) -
A Review of Newly Diagnosed Glioblastoma
por: Oronsky, Bryan, et al.
Publicado: (2021)